Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Southpoint Capital Advisors LP

At a glance: Southpoint Capital Advisors LP is 10% Owner at Fennec Pharmaceuticals (FENC). Their latest SEC Form 4, filed Dec 29, 2025, reported a sale of $7.5M. On file: 0 purchase lines ($0) and 1 sale line ($7.5M).

Disclosed holdings: about $37.6M of FENC stock: 2,744,741 shares (including shares held indirectly, e.g. through a trust or fund) reported on its latest Form 4 (filed Dec 29, 2025), valued at the Nov 19, 2026 close of $13.69. This counts only FENC shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

10% Owner at Fennec Pharmaceuticals Inc. (FENC)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $7.5M

Reported trades

Filed Stock Type Shares Price Value Since
Dec 29SEC FENCFennec Pharmaceuticals Inc. Sell 1,000,0002,744,741 held (−27%) $7.50 $7.5M +82.5%
  • Sell

    10% Owner Southpoint Capital Advisors Lp sold $7.5M of FENC at $7.50 — cuts the stake by 27%.

Follow Southpoint Capital Advisors LP

Get one email when Southpoint Capital Advisors LP files a new purchase or sale. Free.

At most one email a day about Southpoint Capital Advisors LP, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.